News

Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula
Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...
Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer
Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...
STAT6d
Health secretary RFK Jr. declares certain vaccines have ‘never worked,’ flummoxing scientists
Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...
Novavax’s COVID-19 vaccine shows lower side effects vs. Pfizer-BioNTech’s
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
The Many Ways Kennedy Is Already Undermining Vaccines
The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public ...
STAT1d
Vaccine advisory panel, a frequent target of Kennedy, meets with little drama
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Zacks.com on MSN2d
Here's Why Novavax (NVAX) Fell More Than Broader Market
Novavax (NVAX) closed the most recent trading day at $6.39, moving -0.31% from the previous trading session. This move lagged the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a drop ...
Pfizer: Tasty 7% Yield
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...